Intellectual Property (IP)

TechInvention believes in creating intellectual property (IP) through each segment of our product portfolio. We have already created a strong IP foundation in the form of patents, trademarks, copyright, trade secrets, domain names, and other IP rights.

We also support our partners in various intellectual property services like drafting, patent filings, freedom to operate analysis, non-infringement opinions, prior art analysis, patentability analysis, and prosecution of patent applications in India and other countries.

TechInvention’s patents


India


  1. A fully human therapeutic monoclonal antibody against SARS-CoV-2 virus.
  2. Fully human monoclonal antibodies against Chikungunya; provisional patent application.
  3. Recombinant factor H binding proteins (fHbp) of Neisseria meningitidis, their compositions and use thereof.
  4. Modified factor H binding protein vaccine composition.
  5. Method of production of capsular polysaccharide from Streptococcus pneumoniae serotype 15A and its immunogenic compositions for use in vaccines.
  6. A fully human therapeutic monoclonal antibody against SARS-CoV-2 virus.
  7. Process for producing a fully liquid Bi antigenic adjuvant based vaccine against SARS- CoV-2 virus.
  8. Process for producing a fully liquid multi-antigen adjuvant based vaccine against SARS CoV-2 virus.
  9. Process for stable expression of spike subunit protein of SARS-CoV-2 virus in Pichia pastoris for vaccine development.
  10. Increase production of capsular polysaccharide from a virulent Haemophilus influenza type b without the use of external virulence enhancement agents.
  11. Process for production and purification of CRM197 protein of Corynebacterium diphtheriae (ATCC 39255).
  12. Improved process for production and purification of capsular pneumococcal polysaccharide from Streptococcus pneumoniae and method for producing conjugate vaccine composition using said polysaccharide.
  13. Process for production and purification of capsular pneumococcal polysaccharide from Streptococcus pneumoniae or Pneumococcus and method for producing a conjugate vaccine composition using said polysaccharide.

PCT/Other Countries


  1. Lysin polypeptides and compositions thereof against urinary tract infection caused by drug-resistant gram- negative bacteria; international patent application.
  2. Method of production capsular polysaccharide from Streptococcus pneumoniae serotype 15A and its immunogenic compositions for use in vaccines; Eurasian patent application.
  3. Process for producing a fully liquid multi-antigen adjuvant based vaccine against SARS CoV-2 virus; Turkey patent application.

TechInvention’s product trademarks


BIOTHERAPEUTICS DIAGNOSTICS VACCINES
Techmab® SpinTech HIQ™ PneumoWin™
Covimab® GenoDTech™ MenCoVac™
chickvMab® SwiftDTech™ CoviTech™
cmvMab™ ToxoDTech™ CoviTech Plus™
TechLysin® CoviTech Max ™
AcinoLysin® MenBVac™
EcoLysin™ VaxTG™
klebsiLysin® Tech QIV™
AeruLysin™ VaxiTech™
BoostVac™

© 2023 TechInvention. Developed by Scivision Solutions Pvt. Ltd.